Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acaciin
1. 480-36-4
2. Buddleoside
3. Acaciin
4. Linarine
5. Acacetin-7-o-rutinoside
6. Linarigenin Glycoside
7. Acacetin 7-o-rutinoside
8. Hbh2i685iu
9. 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
10. Acacetin 7-rutinoside
11. 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5-hydroxy-2-(4-methoxyphenyl)-4h-benzopyran-4-one
12. 5-hydroxy-2-(4-methoxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
13. Unii-hbh2i685iu
14. Acacetin-7-o-.eta-d-rutinoside
15. Buddleoside,(s)
16. Linarin;buddleoside
17. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-5-hydroxy-2-(4-methoxyphenyl)-
18. 4h-1-benzopyran-4-one, 7-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-5-hydroxy-2-(4-methoxyphenyl)-
19. Einecs 207-547-6
20. Linarin [mi]
21. 5-hydroxy-4'-methoxyflavone-7-o-rutinoside
22. Linarigenin-glucoside
23. Acacetin-7-o-(6''-o-rhamnose)-beta-d-glucoside
24. Chembl509502
25. Schembl1155704
26. Acacetin-7-o-beta-d-rutinoside
27. Dtxsid40197382
28. Acacetin-.beta.-rutinoside
29. Hms3887e11
30. 7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-5-hydroxy-4'-methoxyflavone
31. Hy-n0528
32. Zinc4349491
33. Acacetin 7-o-alpha-l-rhamnopyranosyl-(1->6)-beta-d-glucopyranoside
34. Bdbm50524083
35. Mfcd00151178
36. S9290
37. Stl564542
38. Akos015896769
39. Ac-8009
40. Ccg-270166
41. Cs-0009062
42. 480l364
43. Q-100519
44. Q1775837
45. 5,7-dihydroxy-4-methoxyflavone-d-glucosido-l-rhamnoside
46. 5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4h-chromen-7-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
47. 5-hydroxy-2-(4-methoxyphenyl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
48. 7-((6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-5-hydroxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one
49. 7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-5-hydroxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-one
| Molecular Weight | 592.5 g/mol |
|---|---|
| Molecular Formula | C28H32O14 |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 7 |
| Exact Mass | 592.17920569 g/mol |
| Monoisotopic Mass | 592.17920569 g/mol |
| Topological Polar Surface Area | 214 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 955 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
20
PharmaCompass offers a list of Linarin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Linarin manufacturer or Linarin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linarin manufacturer or Linarin supplier.
PharmaCompass also assists you with knowing the Linarin API Price utilized in the formulation of products. Linarin API Price is not always fixed or binding as the Linarin Price is obtained through a variety of data sources. The Linarin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Linarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linarin, including repackagers and relabelers. The FDA regulates Linarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Linarin supplier is an individual or a company that provides Linarin active pharmaceutical ingredient (API) or Linarin finished formulations upon request. The Linarin suppliers may include Linarin API manufacturers, exporters, distributors and traders.
Linarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Linarin GMP manufacturer or Linarin GMP API supplier for your needs.
A Linarin CoA (Certificate of Analysis) is a formal document that attests to Linarin's compliance with Linarin specifications and serves as a tool for batch-level quality control.
Linarin CoA mostly includes findings from lab analyses of a specific batch. For each Linarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Linarin EP), Linarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linarin USP).
